PD Dr. Dr. Philipp Schommers

Education and Professional Career

  • since 2024: Senior Physician (‘Oberarzt’) Department I of Internal Medicine, University Hospital Cologne, Germany
  • since 2022: Emmy Noether Research Group Leader Department I of Internal Medicine, University Hospital Cologne, Germany
  • 2022: Habilitation (Priv.-Doz.) Venia legendi Internal Medicine University of Cologne 
  • 2022: Board Certification in Infectious Diseases, German Society of Infectious Diseases (DGI)
  • 2021: Board Certification in Internal Medicine, Medical Association of North Rhine (ÄkNo)
  • 2020: PhD Thesis (Dr. nat. med.): “Restriction of HIV-1 Escape by a Novel Highly Broad and Potent Neutralizing Antibody” (“summa cum laude”, highest honor)
  • since 2018: Physician and Clinician Scientist, Department I of Internal Medicine, University Hospital Cologne, Germany Advisor: Prof. Michael Hallek
  • 2016 - 2022: Postdoctoral Associate, Institute of Virology, University of Cologne, Germany, Advisor: Prof. Florian Klein
  • 2015 - 2016: Postdoctoral Associate, Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany, Advisor: Prof. Marcus Altfeld
  • 2015: MD Thesis (Dr. med.): ”Überleben und Mortalität verschiedener HIV-assoziierter Lymphome - Ergebnisse der deutschen HIV-Lymphom-Kohorte“ (“summa cum laude”, highest honor)
  • 2013 - 2015: Physician and Clinician Scientist, Department I of Internal Medicine, University Hospital Cologne, Germany Advisor: Prof. Michael Hallek
  • 2013: Scientific Assistant, Institute for Vegetative Physiology, Center for Physiology and Pathophysiology, University of Cologne, Advisor: Prof. Rudolf Wiesner
  • 2013: Final medical exam 
  • 2007 - 2013: Medical Studies - Germany, Australia and United States

Awards, distinctions and professional activities

  • 2023: Else Kröner Clinician Scientist Professorship - EKFS
  • 2023: 72nd Lindau Nobel Laureate Meeting – Visiting Scientist
  • since 2022: Emmy Noether Grant – German Research Foundation (DFG)
  • 2021-2023: Gilead Research Scholars Program in HIV – Gilead Sciences, Inc.
  • 2022: Science Award - Industrie-Club E.V. Düsseldorf
  • 2021: German Thesis Award – Körber Foundation
  • 2021: German AIDS Award – German AIDS Society (DAIG)
  • 2021: HIV/AIDS Research Award – German Society of Infectious Diseases (DGI)
  • 2020: Wolfgang Stille Award – Paul-Ehrlich-Society of Chemotherapy (PEG)
  • 2020: Graduate Stipend – Novartis foundation for therapeutic research
  • 2017: Meta Alexander Award – German Society of Infectious Diseases (DGI)
  • 2017 - 2018: MD/PhD Stipend – German Center for Infection Research (DZIF)
  • 2016: Lab Rotation Stipend – German Center for Infection Research (DZIF) 
  • 2015 - 2016: Clinical Leave Stipend – German Center for Infection Research (DZIF)
  • 2010 - 2012: Maria-Pesch Scholarship – State of North Rhine-Westphalia

Memberships

  • German Society for Internal Medicine (DGIM)
  • German Society of Infectious Diseases (DGI)
  • Paul-Ehrlich-Society of Chemotherapy (PEG)
  • Deutscher Hochschulverband

Patents

EP 23203489.2

Title: Improved Broadly Neutralizing Antibodies Targeting the CD4 Binding Site on HIV Env

Inventors: Florian Klein, Philipp Schommers, Henning Gruell

Status: Submitted to European Patent Office in 2023

­­

EP 19212986.4

Title: Broadly Neutralizing Antibodies Against HIV

Inventors: Florian Klein, Philipp Schommers, Henning Gruell

Status: Licensed in 2022